{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:35:16Z","timestamp":1787841316532,"version":"build-2784847793"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:sec>\n                    <jats:title>AIM:<\/jats:title>\n                    <jats:p>This study aims to identify clinical features, treatment outcomes, and prognostic factors for relapse and survival in patients with testicular seminoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS:<\/jats:title>\n                    <jats:p>Retrospective analysis of all patients with pure seminoma treated at our center during over a decade (January 2005\u2013December 2014) was carried out. Patient demographics, tumor characteristics, and treatment details and pattern of recurrence were recorded in a structured format, and disease-free survival and overall survival were calculated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Sixty-three patients' case records were included in the analysis. Ten patients developed disease in the undescended testis. All patients underwent orchiectomy as the initial treatment procedure. Majority of the patients were Stage I (57.14%) followed by Stage II (39.6%). Among the patients with Stage I, 55.5% received adjuvant chemotherapy while 22.2% received adjuvant radiation and the rest opted for surveillance. The compliance for active surveillance was very poor. Among patients with Stage II disease, majority (80%) were treated with adjuvant chemotherapy and the rest with radiation. At a median follow-up of 49 months, there were four recurrences of which three were salvaged successfully, and one patient remained alive with disease. There were no disease-related deaths.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Testicular seminoma remains to be relatively low and majority of them presented with Stage I disease and single agent carboplatin appeared to be the preferred adjuvant treatment. Advanced disease patients were treated with etoposide and cisplatin\/bleomycin, etoposide and cisplatin chemotherapy and the clinical outcome is comparable with the Western literature.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijc.ijc_100_17","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T00:43:22Z","timestamp":1513817002000},"page":"385-387","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Testicular seminoma: Are clinical features and treatment outcomes any different in India?"],"prefix":"10.4103","volume":"54","author":[{"given":"M","family":"Anjanappa","sequence":"first","affiliation":[{"name":"Division of Clinical Oncology, Genitourinary Clinic, Regional Cancer Centre, Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Kumar","sequence":"additional","affiliation":[{"name":"Division of Clinical Oncology, Genitourinary Clinic, Regional Cancer Centre, Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Mathews","sequence":"additional","affiliation":[{"name":"Division of Clinical Oncology, Genitourinary Clinic, Regional Cancer Centre, Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Joseph","sequence":"additional","affiliation":[{"name":"Division of Clinical Oncology, Genitourinary Clinic, Regional Cancer Centre, Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KM","family":"Jagathnathkrishna","sequence":"additional","affiliation":[{"name":"Division of Statistics and Cancer Epidemiology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FV","family":"James","sequence":"additional","affiliation":[{"name":"Division of Clinical Oncology, Genitourinary Clinic, Regional Cancer Centre, Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2017,12,1]]},"reference":[{"key":"R1-20250920","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/ijc.20931","article-title":"International patterns and trends in testis cancer incidence","volume":"115","author":"Purdue","year":"2005","journal-title":"Int J Cancer"},{"key":"R2-20250920","first-page":"417","article-title":"Global incidence and outcome of testicular cancer","volume":"5","author":"Shanmugalingam","year":"2013","journal-title":"Clin Epidemiol"},{"key":"R3-20250920","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1200\/JCO.1995.13.9.2255","article-title":"Stage I testicular seminoma: Results of adjuvant irradiation and surveillance","volume":"13","author":"Warde","year":"1995","journal-title":"J Clin Oncol"},{"key":"R4-20250920","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4103\/0970-1591.60451","article-title":"Update on management of seminoma","volume":"26","author":"Alexander","year":"2010","journal-title":"Indian J Urol"},{"key":"R5-20250920","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1200\/JCO.2009.26.4655","article-title":"Randomized trial of carboplatin versus radiotherapy for stage I seminoma: Mature results on relapse and contralateral testis cancer rates in MRC TE19\/EORTC 30982 study (ISRCTN27163214)","volume":"29","author":"Oliver","year":"2011","journal-title":"J Clin Oncol"},{"issue":"Suppl 6","key":"R6-20250920","doi-asserted-by":"crossref","first-page":"vi125","DOI":"10.1093\/annonc\/mdt304","article-title":"Testicular seminoma and non-seminoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Oldenburg","year":"2013","journal-title":"Ann Oncol"},{"key":"R7-20250920","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/jnci\/djq525","article-title":"Randomized trials in 2466 patients with stage I seminoma: Patterns of relapse and follow-up","volume":"103","author":"Mead","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"R8-20250920","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.eururo.2004.01.020","article-title":"Stage II testicular seminoma: Patterns of recurrence and outcome of treatment","volume":"45","author":"Chung","year":"2004","journal-title":"Eur Urol"},{"key":"R9-20250920","first-page":"18","article-title":"Germ cell tumours of the testis: Clinical features, treatment outcome and prognostic factors","volume":"15","author":"Bhutani","year":"2002","journal-title":"Natl Med J India"},{"key":"R10-20250920","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/bjc.1995.77","article-title":"Germ cell tumours in uncorrected cryptorchid testis at Institute Rotary Cancer Hospital, New Delhi","volume":"71","author":"Raina","year":"1995","journal-title":"Br J Cancer"},{"key":"R11-20250920","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0022-5347(01)65582-4","article-title":"Improved management of abdominal undescended testicular tumors with bulky confluent retroperitoneal nodal metastases","volume":"156","author":"Kulkarni","year":"1996","journal-title":"J Urol"},{"key":"R12-20250920","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4103\/0974-7796.115742","article-title":"Role of primary chemotherapy in management of large tumors of undescended testis: Our experience","volume":"5","author":"Sarma","year":"2013","journal-title":"Urol Ann"},{"issue":"16 Suppl","key":"R13-20250920","first-page":"4783","article-title":"Testicular seminoma: Review of 67 cases from India","volume":"23","author":"James","year":"2005","journal-title":"ASCO Annu Meet Proc"},{"key":"R14-20250920","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2002.01.038","article-title":"Prognostic factors for relapse in stage I seminoma managed by surveillance: A pooled analysis","volume":"20","author":"Warde","year":"2002","journal-title":"J Clin Oncol"},{"key":"R15-20250920","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1200\/JCO.1994.12.1.120","article-title":"Advanced seminoma: Treatment results, survival, and prognostic factors in 142 patients","volume":"12","author":"Mencel","year":"1994","journal-title":"J Clin Oncol"},{"key":"R16-20250920","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00345-009-0431-z","article-title":"Good-risk-advanced germ cell tumors: Historical perspective and current standards of care","volume":"27","author":"Feldman","year":"2009","journal-title":"World J Urol"},{"key":"R17-20250920","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.eururo.2013.09.004","article-title":"Arisk-adapted study of cisplatin and etoposide, with or without ifosfamide, in patients with metastatic seminoma: Results of the GETUG S99 multicenter prospective study","volume":"65","author":"Fizazi","year":"2014","journal-title":"Eur Urol"}],"container-title":["Indian Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/02223310-201754010-00079","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:49:40Z","timestamp":1787838580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/02223310-201754010-00079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.4103\/ijc.ijc_100_17","relation":{},"ISSN":["0019-509X","1998-4774"],"issn-type":[{"value":"0019-509X","type":"print"},{"value":"1998-4774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}